Cardiovascular disease risk in an aging HIV population: not just a question of biology
- PMID: 24824885
- PMCID: PMC4321776
- DOI: 10.1097/COH.0000000000000065
Cardiovascular disease risk in an aging HIV population: not just a question of biology
Abstract
Purpose of review: The objective of this review is to appraise recently published literature that describes the relationship between HIV, biologic and environmental risk factors, and cardiovascular disease (CVD) risk with particular emphasis on the aging HIV population and to demonstrate that these biologic and environmental factors may interact to increase the risk of CVD in the HIV population.
Recent findings: The mechanisms linking HIV and CVD are multifactorial and encompass biological and 'environmental' modalities including multimorbid conditions that co-occur with HIV, immunologic alterations associated with HIV, polypharmacy (which affects adherence and increases likelihood of adverse drug-drug interactions) and healthcare disparities in CVD risk reduction by HIV status.
Summary: Data regarding optimal treatment strategies that balance immunological restoration and CVD risk reduction are needed.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.BMC Infect Dis. 2017 Sep 11;17(1):611. doi: 10.1186/s12879-017-2692-2. BMC Infect Dis. 2017. PMID: 28893184 Free PMC article.
-
Cardiovascular health in an aging HIV population.AIDS. 2017 Jun 1;31 Suppl 2:S157-S163. doi: 10.1097/QAD.0000000000001384. AIDS. 2017. PMID: 28471946 Review.
-
Cardiovascular disease in HIV infection.Curr Opin HIV AIDS. 2011 Jul;6(4):266-71. doi: 10.1097/COH.0b013e328347876c. Curr Opin HIV AIDS. 2011. PMID: 21546831 Free PMC article. Review.
-
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort.AIDS. 2018 Oct 23;32(16):2405-2416. doi: 10.1097/QAD.0000000000001967. AIDS. 2018. PMID: 30134296
-
HIV infection, aging and cardiovascular disease: epidemiology and prevention.Sex Health. 2011 Dec;8(4):465-73. doi: 10.1071/SH11020. Sex Health. 2011. PMID: 22127031 Review.
Cited by
-
Perceived barriers to smoking cessation and perceptions of electronic cigarettes among persons living with HIV.AIDS Care. 2018 Nov;30(11):1469-1475. doi: 10.1080/09540121.2018.1489103. Epub 2018 Jun 21. AIDS Care. 2018. PMID: 29927614 Free PMC article.
-
Alcohol and dietary factors associate with gut integrity and inflammation in HIV-infected adults.HIV Med. 2017 Jul;18(6):402-411. doi: 10.1111/hiv.12442. Epub 2016 Nov 9. HIV Med. 2017. PMID: 27860212 Free PMC article. Clinical Trial.
-
A multinational qualitative investigation of the perspectives and drivers of exercise and dietary behaviors in people living with HIV.Appl Nurs Res. 2017 Oct;37:13-18. doi: 10.1016/j.apnr.2017.07.002. Epub 2017 Jul 5. Appl Nurs Res. 2017. PMID: 28985914 Free PMC article.
-
Inflammatory and Cardiovascular Correlates of Physical Activity and Sedentary Behavior in Older Adults Living With HIV.J Phys Act Health. 2023 Jan 14;20(2):149-156. doi: 10.1123/jpah.2022-0304. Print 2023 Feb 1. J Phys Act Health. 2023. PMID: 36640774 Free PMC article.
-
Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.J Am Coll Cardiol. 2015 Feb 24;65(7):738-44. doi: 10.1016/j.jacc.2014.12.014. J Am Coll Cardiol. 2015. PMID: 25677433 Free PMC article. Review.
References
Annotated bibliography
-
- Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV Infection and the Risk of Acute Myocardial Infarction. JAMA internal medicine. 2013 Mar;4:1–9. Epub 2013/03/06. Eng. *This work shows an association between HIV and myocardial infarction, a CVD outcome that is relatively distinct (minimize event ascertainment bias). Importantly, the study uses adjudicated events, clinical data, a large well characterized cohort, a demographically and behaviorally similar uninfected group, time-dependent covariate analysis. - PMC - PubMed
-
- Silverberg MJ, Leyden WA, Xu L, Horberg MA, Chao CR, Towner WJ, et al. Immunodeficiency and Risk of Myocardial Infarction Among HIV-Positive Individuals With Access to Care. J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):160–6. **This work shows an association between HIV and myocardial infarction, a CVD outcome that is relatively distinct (minimize event ascertainment bias). Importantly, the study benefits from a very large well characterized cohort, a demographically matched uninfected group, time-dependent covariate analysis. - PubMed
-
- Monroe AK, Dobs AS, Xu X, Palella FJ, Kingsley LA, Post WS, et al. Low free testosterone in HIV-infected men is not associated with subclinical cardiovascular disease. HIV Med. 2012 Jul;13(6):358–66. *Relatively large study (N= 856) from MACS cohort looking at coronary artery calcium and HIV infection status. - PMC - PubMed
-
- Hsue PY, Scherzer R, Hunt PW, Schnell A, Bolger AF, Kalapus SC, et al. Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation. Journal of the American Heart Association. 2012 Apr;1(2) *Study design involved stratifiying HIV infected group by treatment status and detectable HIV viremia. Two regions of carotid artery imaged and analyzed separately and longitudinal analysis performed. Study links HIV associated inflammaiton with atherosclerosis within the same cohort. - PMC - PubMed
-
- Rose H, Low H, Dewar E, Bukrinsky M, Hoy J, Dart A, et al. The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study. Atherosclerosis. 2013 Jul;229(1):206–11. *Study investigates multiple steps in a proposed mechanism involving HIV, ART, lipid dysregulation and atherosclerosis within a single cohort. - PMC - PubMed
References
-
- Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):179–87. Epub 2006/11/01. eng. - PubMed
-
- Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011 Dec;53(11):1130–9. - PubMed
-
- Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med. 2013 Apr;14(4):195–207. - PubMed
-
- Ehren K, Hertenstein C, Kummerle T, Vehreschild JJ, Fischer J, Gillor D, et al. Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection. 2013 Oct 1; - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials